Collecting duct carcinomas of the kidney: A comparative loss of heterozygosity study with clear cell renal cell carcinoma

Oncology Reports

Volumn 5, Issue 4, 1998, Pages 923-926

  Fogt, Franz ^a   Zhuang, Zhengping ^b   Marston Linehan, W ^b   Merino, Maria J ^b  

^a PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Collecting duct carcinoma; Loss of heterozygosity; Von Hippel Lindau gene

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CLEAR CELL CARCINOMA; GENE DELETION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; PRIORITY JOURNAL;

EID: 0031812309     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.4.923     Document Type: Article

References (27)

1. Fleming S and Lewi HJ: Collecting duct carcinoma of the kidney. Histopathology 10: 1131-1141, 1986.
2. Carter MD, Tha S, McLoughlin MG and Owen DA: Collecting duct carcinoma of the kidney: a case report and review of the literature. J Urol 147: 1096-1098, 1992.
3. Graver RD, Correra H, Crapanzano JP, Kumar SR and Gardner RV: Renal collecting duct carcinoma in an 8-year old child. Pediat Nephrol 10: 29-32, 1996.
4. Caraway NP, Wojcik EM, Katz RL, Ro JY and Ordonez NG: Cytologic findings of collecting duct carcinoma of the kidney. Diagn Cytopathol 13: 304-309, 1995.
5. Thrash-Bingham C, Salazar H, Freed JJ, Greenberg RE and Tartof K: Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Cancer Res 55: 6189-6195, 1995.
6. Dalbagni G, Presti J, Reuter V, Fair WR and Cordon-Cardo C: Genetic alterations in bladder cancer. Lancet 432: 469-471, 1993.
7. Li M, Zhang ZF, Reuter VE and Cordon-Cardo C: Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinomas of the urinary bladder. Am J Pathol 149: 229-235, 1996.
8. Schoenberg M, Cairns P, Brooks JD, Marshall FF, Epstein JI, Isaacs WB and Sidransky D: Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney. Genes Chromosomes Cancer 12: 76-80, 1995.
9. Presti JC, Reuter VE, Cordon-Cardo C, Mazumdar M, Fair WR and Jhanwar SC: Allelic deletions in renal tumors: histopathological correlations. Cancer Res 53: 5780-5783, 1993.
10. Ruppert JM. Tokino K and Sidransky D: Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 53: 5093-5095, 1993.
11. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, Hittelman W and Hong WK: Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 2: 682-685, 1996.
12. Zhuang Z, Bertheau P, Emmert-Buck M, Liotta L, Gnarra J, Linehan W and Lubensky IA: A new microdissection technique for archival DNA analysis of specific cell populations in lesions less than one millimeter in size. Am J Pathol 146: 620-625, 1995.
13. Dimopoulos MA, Logothetis CI, Markowitz A, Sella A. Amato R and Ro J: Collecting duct carcinoma of the kidney. Br J Urol 71: 388-391, 1993.
14. Kennedy SM, Merino MJ, Linehan WM, Roberts JR, Robertson CN, Neumann RD: Collecting duct carcinomas of the kidney. Hum Pathol 21: 449-456, 1990.
15. Mostofi FK: Potentialities of bladder epithelium. J Urol 71: 705-714, 1954.
16. Gnarra JR, Lerman MI, Zbar B and Linehan WM: Genetics of renal cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Semin Oncol 22: 3-8, 1995.
17. Gruis NA, Weaver-Feldhaus J, Liu Q, Frye C, Eeles R, Orlow I, Lacombe L, Ponce-Castaneda V, Lianes P, Latres E, Skolnick M, Cordon-Cardo C and Kamb A: Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression. Am J Pathol 146: 1199-1206, 1995.
18. Uchida T, Wada C, Ishida H, Wang C, Egawa S, Yokoyama E, Kameya T and Koshiba K: p53 mutations and prognosis in bladder tumors. J Urol 153: 1097-1104, 1995.
19. Yoshimura I, Kudoh J, Tazaki H and Shimizu N: p53 gene mutation in recurrent superficial bladder cancer. J Urol 153: 1711-1715, 1995.
20. Knowles MA: Molecular genetics of bladder cancer. Br J Urol 75 (Suppl 1): 57-66, 1995.
21. Orlow I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Dalbagni G, Reuter VE, Zhang ZF, Beach D and Cordon-Cardo C: Deletion of the p16 and p15 genes in human bladder tumors J Natl Cancer Inst 87: 1524-1529, 1995.
22. Williamson MP, Elder PA, Shaw ME, Devlin J and Knowles MA: p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet 4: 1569-1577, 1995.
23. IK4A MTS1) gene and other loci on human chromosome 9. Int J Cancer 65: 840-846, 1996.
24. Serrano M, Hannon GJ and Beach D: A new regulatory motif in cell cycle control causing specific inhibition of D/CDK4. Nature 366: 704-707, 1993.
25. Rodabaugh KJ, Biggs RB, Qureshi JA, Barrett AJ, Welch WR, Bell DA, Berkowitz RS and Mok SC: Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors. Oncogene 11: 1249-1254, 1995.
26. Morita R, Ishikawa J, Tsutsumi M, Hikiji K, Tsukada Y, Kamidono S, Maeda S and Nakamura Y: Allelotype of renal cell carcinoma. Cancer Res 51: 820-823, 1991.
27. Cairns P, Tokino K, Eby Y and Sidransky D: Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res 55: 224-227, 1995.